The thing that kills most hantavirus patients is the gap between feeling like they have the flu and being on a ventilator. That gap is usually 24 to 48 hours. Patients who walk into an ER and mention they cleaned out a cabin or shed in the past month get to the ICU faster than patients who do not. CDC surveillance covering all confirmed US cases since the 1993 Four Corners outbreak puts the case fatality rate at roughly 36 percent.

That number is the central fact of this disease. Hantavirus pulmonary syndrome (HPS) does not give a long warning. It hides as a routine viral illness, then crashes the lungs in the span of a single shift. For background on rodent reservoirs and exposure routes, start with our piece on the hantavirus rodent-borne risk. For the broader playbook on avoiding zoonotic exposure, see the infection prevention guide.

Key Takeaways

What is hantavirus pulmonary syndrome?

Hantavirus pulmonary syndrome is a severe respiratory illness caused by hantaviruses transmitted from rodents through inhaled aerosolized droppings, urine, or saliva. In North America, Sin Nombre virus is the dominant strain. The disease attacks pulmonary capillaries, causes massive fluid leak into the lungs, and progresses to respiratory failure with little warning.

The 1993 Four Corners outbreak put HPS on the map. Healthy young adults in the high desert region where Arizona, Colorado, New Mexico, and Utah meet started dying of unexplained respiratory failure within days of a flu-like illness. CDC investigators traced it to deer mice and a previously unknown hantavirus, later named Sin Nombre virus.

Since 1993, CDC has confirmed roughly 850 HPS cases in the US, averaging 20 to 30 per year. Cases cluster in western states but have been reported in 36 states. Deer mouse range covers nearly all of North America, so geographic risk is wider than the case map suggests.

What are the early symptoms (the prodromal phase)?

The prodromal phase of HPS lasts 3 to 6 days and is dominated by fever, severe muscle aches, fatigue, and headache. Roughly half of patients also have nausea, vomiting, abdominal pain, or diarrhea. There is no cough, no shortness of breath, no chest pain in this phase. That absence is exactly what makes it dangerous.

You feel like you have the flu. So does your doctor. The prodromal phase is clinically indistinguishable from influenza, COVID-19, or other common viral illnesses without specific testing or a strong exposure history. CDC patient series describe the muscle aches as severe and concentrated in large muscle groups: thighs, hips, lower back, shoulders.

Incubation runs 1 to 5 weeks after exposure, with a median around 2 to 3 weeks. So if you cleaned out a shed three weeks ago and now feel like you have a brutal flu with deep muscle pain, that timeline matters. Tell your doctor.

Day from symptom onset Phase Typical symptoms
1 to 2 Prodromal Fever, severe muscle aches, headache, fatigue
3 to 4 Prodromal Nausea, vomiting, abdominal pain, diarrhea (about half of cases)
4 to 6 Prodromal to cardiopulmonary Sudden cough, shortness of breath, chest tightness
5 to 8 Cardiopulmonary Pulmonary edema, hypoxia, hypotension, shock
8 to 14 Recovery or fatal ICU support, mechanical ventilation, possible ECMO

What happens during the cardiopulmonary phase?

The cardiopulmonary phase begins abruptly with cough, shortness of breath, and a feeling of chest tightness. Within hours, capillaries in the lungs leak plasma into the alveolar spaces. Patients drown in their own fluid. Blood pressure crashes as cardiac output falls. Without ICU-level support, death from respiratory failure or cardiogenic shock can follow within 24 to 48 hours of the first respiratory symptom.

Lab findings during this phase are distinctive enough that experienced clinicians can recognize HPS at the bedside. The classic pattern is hemoconcentration (rising hematocrit as plasma leaks out of vessels), thrombocytopenia (often below 150,000), a left shift with circulating immunoblasts, and falling serum albumin. A chest X-ray that was clear two days earlier shows diffuse bilateral infiltrates resembling ARDS.

The heart is also affected. Cardiac index drops, lactic acidosis worsens, and patients can die of cardiogenic shock as well as respiratory failure. About 60 to 70 percent of confirmed cases require mechanical ventilation, and a meaningful fraction needs ECMO to survive the first 72 hours.

Why is the 24 to 48 hour window the critical variable?

The 24 to 48 hour window between the first respiratory symptom and respiratory failure is the entire treatment window for HPS. No antiviral reliably works. Survival depends on getting the patient to a center with ICU capacity, ideally one with ECMO, before the lungs fail completely. Patients who arrive before needing intubation have substantially better outcomes than patients who arrive in extremis.

This is why exposure history matters so much. A patient on day four of fever and muscle aches with a new cough, who tells the triage nurse they swept out a cabin a month ago, gets a chest X-ray, hematocrit, platelet count, and ICU consult. A patient with the same presentation who does not mention the cabin gets sent home with a presumed viral syndrome. Twelve hours later they come back in respiratory failure, and the window has closed.

CDC retrospectives of fatal cases find that delayed recognition is the strongest modifiable predictor of death. The difference is whether someone connects the dusty shed three weeks ago to the cough today. If you have been near rodent droppings recently and you feel sick, say it out loud.

Who has the highest risk of fatal outcome?

Risk of death from HPS is highest in patients who present late and in patients with comorbidities that limit cardiopulmonary reserve. Age above 50, pre-existing heart disease, chronic lung disease, and immune compromise all worsen outcomes. Pregnancy raises risk. Healthy young adults can still die, and the 1993 outbreak was notable for killing previously healthy people in their 20s and 30s.

Geographic and occupational factors shape exposure risk, not fatality risk once infected. Cabin owners opening seasonal properties, agricultural workers cleaning grain storage, hikers using backcountry shelters, and anyone cleaning rodent-infested spaces without protection make up the typical patient profile. The 2012 Yosemite outbreak killed three of ten visitors who stayed in tent cabins where deer mice had colonized insulated walls.

Pediatric HPS is uncommon but not rare. Children present similarly to adults, with comparable 30 to 40 percent mortality. Recognition is often slower because the prodromal phase looks even more like routine viral illness.

What does HPS treatment look like?

HPS treatment is supportive. There is no licensed antiviral, no monoclonal antibody, and no human vaccine in the US. Care centers on aggressive ICU support: intubation with low tidal volumes, careful fluid management to support blood pressure without flooding the lungs, vasopressors for shock, and ECMO for the sickest patients.

Ribavirin, an antiviral with activity against some hantaviruses, has been studied for HPS without clear benefit. It is used routinely for hemorrhagic fever with renal syndrome (HFRS), the Old World hantavirus disease, but most US centers skip it for HPS. Convalescent plasma and the monoclonal antibody candidate SAB-159 remain investigational.

ECMO is the difference between life and death for the sickest patients. Series from regional ECMO centers in the western US report survival rates above 60 percent in HPS patients placed on veno-arterial ECMO during the cardiogenic shock phase. Getting a deteriorating patient to an ECMO-capable center before they arrest is the most consequential decision in the entire clinical course.

FAQ

How quickly do hantavirus symptoms progress?

The prodromal phase lasts 3 to 6 days with fever and severe muscle aches. Then symptoms shift. Once cough and shortness of breath appear, respiratory failure can follow within 24 to 48 hours. That transition is faster than almost any other community-acquired respiratory infection.

Can hantavirus be mistaken for COVID-19 or flu?

Yes, in the prodromal phase. Fever, muscle aches, headache, and fatigue without cough match dozens of viral illnesses. The differentiating clue is exposure history (rodent contact in the prior 1 to 5 weeks) plus characteristic labs (rising hematocrit, low platelets, immunoblasts) once they appear. Without exposure history, early HPS is routinely missed.

Is there a hantavirus test that confirms diagnosis quickly?

Yes. CDC and most state public health labs run IgM and IgG ELISA serology and RT-PCR on serum. Results often return within 24 to 48 hours from a state lab and faster from CDC during outbreaks. Treatment cannot wait for confirmation, however. Suspected HPS patients go to the ICU on clinical grounds and get tested in parallel.

Do hantavirus survivors have long-term complications?

Most survivors recover fully within weeks to months. Some report reduced exercise tolerance, mild lung function abnormalities, or fatigue lasting up to a year. Severe cases who needed prolonged ventilation may have post-ICU syndrome with cognitive and physical deficits. Long-term renal or pulmonary sequelae specific to the virus are uncommon in HPS, unlike HFRS.

Should I go to the ER for a flu-like illness after cleaning a shed?

If you have severe muscle aches and fever within 1 to 5 weeks of cleaning a rodent-infested space, yes. Tell the triage nurse about the exposure on arrival, not after they ask. A normal chest X-ray and stable vitals are reassuring but do not rule out prodromal HPS. Ask about observation or follow-up testing given the timeline.